phase readout
saveNCT04136353: Darolutamide Augments Standard Therapy for Localised Very High-Risk Cancer of the Prostate
ACTIVE_NOT_RECRUITINGupdated 4d ago
community read0 votes
Sponsor: University of Sydney. Phase: PHASE3. Conditions: Prostate Cancer
view source ↗
comments(0)
5-min edit window · permanent after that